Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Oh

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 25, 2018
Deep and Durable Response With Combination CTLA-4 and PD-1 Blockade in Mismatch Repair (MMR)-proficient Endometrial CancerMichael S Oh, Young Kwang Chae
JCO Precision Oncology|February 9, 2022
Repeated Abscopal Effect With Radiotherapy and Programmed Death 1 Blockade in Mismatch Repair-Deficient Endometrial CancerMichael S Oh, Young Kwang Chae
Clinical Lung Cancer|September 20, 2021
Reply to Letter to the EditorMichael S Oh, Victoria M Villaflor
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 9, 2018
Detection of Minimal Residual Disease Using ctDNA in Lung Cancer: Current Evidence and Future DirectionsYoung Kwang Chae, Michael S Oh
Cancer Treatment and Research Communications|March 12, 2021
High gene expression of estrogen and progesterone receptors is associated with decreased t cell infiltration in patients with NSCLCMichael S Oh, Jonathan F Anker, Young Kwang Chae
The Oncologist|December 16, 2017
Molecular Biomarkers of Primary and Acquired Resistance to T-Cell-Mediated Immunotherapy in Cancer: Landscape, Clinical Implications, and Future DirectionsYoung Kwang Chae, Michael S Oh, Francis J Giles
Cancers|March 28, 2025
Tumor Heterogeneity and the Immune Response in Non-Small Cell Lung Cancer: Emerging Insights and Implications for ImmunotherapyMichael S Oh, Jensen Abascal, Austin K Rennels, et al.
Cells|October 13, 2023
Dendritic Cell Vaccination in Non-Small Cell Lung Cancer: Remodeling the Tumor Immune MicroenvironmentJensen Abascal, Michael S Oh, Elvira L Liclican, et al.
Clinical Epidemiology|July 2, 2020
Peripartum Blood Transfusions are Associated with Increased Risk of Cancer: A National Retrospective Cohort StudyGeum Joon Cho, Michael S Oh, Min-Jeong Oh, et al.
Clinical Lung Cancer|September 9, 2020
The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint InhibitorsMichael S Oh, Alex Guzner, Derek A Wainwright, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 25, 2018
Deep and Durable Response With Combination CTLA-4 and PD-1 Blockade in Mismatch Repair (MMR)-proficient Endometrial CancerMichael S Oh, Young Kwang Chae
JCO Precision Oncology|February 9, 2022
Repeated Abscopal Effect With Radiotherapy and Programmed Death 1 Blockade in Mismatch Repair-Deficient Endometrial CancerMichael S Oh, Young Kwang Chae
Clinical Lung Cancer|September 20, 2021
Reply to Letter to the EditorMichael S Oh, Victoria M Villaflor
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 9, 2018
Detection of Minimal Residual Disease Using ctDNA in Lung Cancer: Current Evidence and Future DirectionsYoung Kwang Chae, Michael S Oh
Cancer Treatment and Research Communications|March 12, 2021
High gene expression of estrogen and progesterone receptors is associated with decreased t cell infiltration in patients with NSCLCMichael S Oh, Jonathan F Anker, Young Kwang Chae
The Oncologist|December 16, 2017
Molecular Biomarkers of Primary and Acquired Resistance to T-Cell-Mediated Immunotherapy in Cancer: Landscape, Clinical Implications, and Future DirectionsYoung Kwang Chae, Michael S Oh, Francis J Giles
Cancers|March 28, 2025
Tumor Heterogeneity and the Immune Response in Non-Small Cell Lung Cancer: Emerging Insights and Implications for ImmunotherapyMichael S Oh, Jensen Abascal, Austin K Rennels, et al.
Cells|October 13, 2023
Dendritic Cell Vaccination in Non-Small Cell Lung Cancer: Remodeling the Tumor Immune MicroenvironmentJensen Abascal, Michael S Oh, Elvira L Liclican, et al.
Clinical Epidemiology|July 2, 2020
Peripartum Blood Transfusions are Associated with Increased Risk of Cancer: A National Retrospective Cohort StudyGeum Joon Cho, Michael S Oh, Min-Jeong Oh, et al.
Clinical Lung Cancer|September 9, 2020
The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint InhibitorsMichael S Oh, Alex Guzner, Derek A Wainwright, et al.
Pageof 3